SCIENTIFIC AND MEDICAL ACCOUNTABILITY STANDARDS WORKING
GROUP
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

PUBLIC SESSION:                OSAKA ROOM

1. Welcome.
2. Call to Order & Roll Call.
3. Staff report.
      a.  Summary and Response to Public Comment for the Proposed Revisions to CIRM MES Regulations 100080, 100100
      b. Revisions
4. Scientific presentations and group discussion of current issues in stem cell science.
       a. Clinical trials
       b. iPS experiments
5. Report on CIRM Guidelines for Oocyte Donation.
6. Report and discussion of regulatory consideration for CIRM MES regulations.
7. Adjournment.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at (415) 396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific and Medical Research Funding Working Group meeting may be referred to Pat Beaupre Becker at the California Institute for Regenerative Medicine at pbecker@cirm.ca.gov or (415) 396-9105.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.